Ceribell, Stock Current Valuation
| CBLL Stock | 28.79 0.05 0.17% |
Valuation analysis of CeriBell, helps investors to measure CeriBell,'s intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At this time, CeriBell,'s Cash is quite stable compared to the past year. End Period Cash Flow is expected to rise to about 41.1 M this year, although the value of Change In Cash is projected to rise to (32.1 M).
Undervalued
Today
Please note that CeriBell,'s price fluctuation is somewhat reliable at this time. Calculation of the real value of CeriBell, is based on 3 months time horizon. Increasing CeriBell,'s time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CeriBell, stock is determined by what a typical buyer is willing to pay for full or partial control of CeriBell,. Since CeriBell, is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CeriBell, Stock. However, CeriBell,'s intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 28.79 | Real 30.54 | Hype 28.79 | Naive 28.38 |
The intrinsic value of CeriBell,'s stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CeriBell,'s stock price.
Estimating the potential upside or downside of CeriBell, helps investors to forecast how CeriBell, stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CeriBell, more accurately as focusing exclusively on CeriBell,'s fundamentals will not take into account other important factors: CeriBell, Company Current Valuation Analysis
CeriBell,'s Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CeriBell, Current Valuation Driver Correlations
Understanding the fundamental principles of building solid financial models for CeriBell, is extremely important. It helps to project a fair market value of CeriBell, Stock properly, considering its historical fundamentals such as Current Valuation. Since CeriBell,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CeriBell,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CeriBell,'s interrelated accounts and indicators.
Click cells to compare fundamentals
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, CeriBell, has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The current valuation for all United States stocks is 100.0% higher than that of the company.
CeriBell, Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CeriBell,'s direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CeriBell, could also be used in its relative valuation, which is a method of valuing CeriBell, by comparing valuation metrics of similar companies.CeriBell, is currently under evaluation in current valuation category among its peers.
CeriBell, Fundamentals
| Total Debt | 11.83 M | ||||
| Number Of Employees | 229 | ||||
| Total Asset | 58.92 M | ||||
| Retained Earnings | (126.49 M) | ||||
| Working Capital | 30.36 M | ||||
| Net Asset | 58.92 M |
About CeriBell, Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze CeriBell,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeriBell, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeriBell, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out CeriBell, Piotroski F Score and CeriBell, Altman Z Score analysis. For more information on how to buy CeriBell, Stock please use our How to buy in CeriBell, Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell,. If investors know CeriBell, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CeriBell, is measured differently than its book value, which is the value of CeriBell, that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell,'s value that differs from its market value or its book value, called intrinsic value, which is CeriBell,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell,'s market value can be influenced by many factors that don't directly affect CeriBell,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.